In addition, there are also pathological situations in which circulating IGF-signaling is decreased, such as diabetes and Alzheimer’s disease (Torres-Aleman, 2005; Fernandez et al., 2018). This evidence concerns the gene IGF1 and early-onset autosomal dominant Alzheimer disease.